Osteopontin O-glycosylation contributes to its phosphorylation and cell-adhesion properties

Biochemical Journal

Volumn 463, Issue 1, 2014, Pages 93-102

  Kariya, Yoshinobu ^a   Kanno, Mayumi ^a   Matsumoto Morita, Kana ^b   Konno, Midori ^a   Yamaguchi, Yoshiki ^b   Hashimoto, Yasuhiro ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b RIKEN   (Japan)

Author keywords

Cell spreading; Integrin; O glycan defect; O glycosylation; Osteopontin; Phosphorylation

Indexed keywords

GLYCAN DERIVATIVE; INTEGRIN; MUTANT PROTEIN; OSTEOPONTIN; POLYCLONAL ANTIBODY; PROLINE; RECOMBINANT OSTEOPONTIN; RECOMBINANT PROTEIN; SIALIDASE; THREONINE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; CELL ADHESION; CELL SPREADING; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR SIZE; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEPHOSPHORYLATION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; WILD TYPE; GENETICS; GLYCOSYLATION; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

CELL ADHESION; CELL LINE, TUMOR; GLYCOSYLATION; HEK293 CELLS; HUMANS; INTEGRIN ALPHAVBETA3; OSTEOPONTIN; PHOSPHORYLATION;

EID: 84906983998     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20140060     Document Type: Article

References (29)

1. Sodek, J., Ganss, B. and McKee, M. D. (2000) Osteopontin. Crit. Rev. Oral Biol. Med. 11, 279-303 CrossRef PubMed.
2. Kazanecki, C. C., Uzwiak, D. J. and Denhardt, D. T. (2007) Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J. Cell Biochem. 102, 912-924 CrossRef PubMed.
3. Franzen, A. and Heinegard, D. (1985) Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem. J. 232, 715-724 PubMed.
4. Christensen, B., Nielsen, M. S., Haselmann, K. F., Petersen, T. E. and Sorensen, E. S. (2005) Post-translationally modified residues of native human osteopontin are located in clusters identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem. J. 390, 285-292 CrossRef PubMed.
5. Sorensen, E. S., Hojrup, P. and Petersen, T. E. (1995) Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci. 4, 2040-2049 CrossRef PubMed.
6. Prince, C. W., Oosawa, T., Butler, W. T., Tomana, M., Bhown, A. S., Bhown, M. and Schrohenloher, R. E. (1987) Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J. Biol. Chem. 262, 2900-2907 PubMed.
7. Christensen, B., Petersen, T. E. and Sorensen, E. S. (2008) Post-translational modification and proteolytic processing of urinary osteopontin. Biochem. J. 411, 53-61 CrossRef PubMed.
8. Christensen, B., Klaning, E., Nielsen, M. S., Andersen, M. H. and Sorensen, E. S. (2012) C-terminal modification of osteopontin inhibits interaction with the alphaVbeta3-integrin. J. Biol. Chem. 287, 3788-3797 CrossRef PubMed.
9. Ek-Rylander, B., Flores, M., Wendel, M., Heinegard, D. and Andersson, G. (1994) Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J. Biol. Chem. 269, 14853-14856 PubMed.
10. Nemir, M., DeVouge, M. W. and Mukherjee, B. B. (1989) Normal rat kidney cells secrete both phosphorylated and nonphosphorylated forms of osteopontin showing different physiological properties. J. Biol. Chem. 264, 18202-18208 PubMed.
11. Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J. and Cantor, H. (2000) Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 287, 860-864 CrossRef PubMed.
12. Shanmugam, V., Chackalaparampil, I., Kundu, G. C., Mukherjee, A. B. and Mukherjee, B. B. (1997) Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 cells. Biochemistry 36, 5729-5738 CrossRef PubMed.
13. Julien, S., Lagadec, C., Krzewinski-Recchi, M. A., Courtand, G., Le Bourhis, X. and Delannoy, P. (2005) Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration. Breast Cancer Res. Treat. 90, 77-84 CrossRef PubMed.
14. Clement, M., Rocher, J., Loirand, G. and Le Pendu, J. (2004) Expression of sialyl-Tn epitopes on beta1 integrin alters epithelial cell phenotype, proliferation and haptotaxis. J. Cell Sci. 117, 5059-5069 CrossRef PubMed.
15. Christensen, B., Kazanecki, C. C., Petersen, T. E., Rittling, S. R., Denhardt, D. T. and Sorensen, E. S. (2007) Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J. Biol. Chem. 282, 19463-19472 CrossRef PubMed.
16. Hollingsworth, M. A. and Swanson, B. J. (2004) Mucins in cancer: Protection and control of the cell surface. Nat. Rev. Cancer. 4, 45-60 CrossRef PubMed.
17. Cazet, A., Julien, S., Bobowski, M., Burchell, J. and Delannoy, P. (2010) Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res. 12, 204 CrossRef PubMed.
18. Julien, S., Picco, G., Sewell, R., Vercoutter-Edouart, A. S., Tarp, M., Miles, D., Clausen, H., Taylor-Papadimitriou, J. and Burchell, J. M. (2009) Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model. Br. J. Cancer. 100, 1746-1754 CrossRef PubMed.
19. Kariya, Y., Ishida, K., Tsubota, Y., Nakashima, Y., Hirosaki, T., Ogawa, T. and Miyazaki, K. (2002) Efficient expression system of human recombinant laminin-5. J. Biochem. 132, 607-612 CrossRef PubMed.
20. Rappsilber, J., Ishihama, Y. and Mann, M. (2003) Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663-670 CrossRef PubMed.
21. Taus, T., Kocher, T., Pichler, P., Paschke, C., Schmidt, A., Henrich, C. and Mechtler, K. (2011) Universal and confident phosphorylation site localization using phosphoRS. J. Proteome Res. 10, 5354-5362 CrossRef PubMed.
22. Pinon, P., Parssinen, J., Vazquez, P., Bachmann, M., Rahikainen, R., Jacquier, M. C., Azizi, L., Maatta, J. A., Bastmeyer, M., Hytonen, V. P. and Wehrle-Haller, B. (2014) Talin-bound NPLY motif recruits integrin-signaling adapters to regulate cell spreading and mechanosensing. J. Cell Biol. 205, 265-281 CrossRef PubMed.
23. Kariya, Y. and Gu, J. (2011) N-glycosylation of β4 integrin controls the adhesion and motility of keratinocytes. PLoS ONE 6, e27084 CrossRef PubMed.
24. Garner, B., Merry, A. H., Royle, L., Harvey, D. J., Rudd, P. M. and Thillet, J. (2001) Structural elucidation of the N- And O-glycans of human apolipoprotein(a): role of O-glycans in conferring protease resistance. J. Biol. Chem. 276, 22200-22208 CrossRef PubMed.
25. Matsuki, H., Yonezawa, K., Obata, K., Iwata, K., Nakamura, H., Okada, Y. and Seiki, M. (2003) Monoclonal antibodies with defined recognition sequences in the stem region of CD44: Detection of differential glycosylation of CD44 between tumor and stromal cells in tissue. Cancer Res. 63, 8278-8283 PubMed.
26. Singh, K., DeVouge, M. W. and Mukherjee, B. B. (1990) Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells. J. Biol. Chem. 265, 18696-18701 PubMed.
27. Tagliabracci, V. S., Engel, J. L., Wen, J., Wiley, S. E., Worby, C. A., Kinch, L. N., Xiao, J., Grishin, N. V. and Dixon, J. E. (2012) Secreted kinase phosphorylates extracellular proteins that regulate biomineralization. Science 336, 1150-1153 CrossRef PubMed.
28. Hart, G. W., Housley, M. P. and Slawson, C. (2007) Cycling of O-linked beta-Nacetylglucosamine on nucleocytoplasmic proteins. Nature 446, 1017-1022 CrossRef PubMed.
29. Brockhausen, I. (2006) Mucin-type O-glycans in human colon and breast cancer glycodynamics and functions. EMBO Rep. 7, 599-604 CrossRef PubMed.